BBK inks deal to buy mobile app development unit

BBK Holdings has struck a deal to buy MEDL Mobile Holdings' custom app development unit. The acquisition tightens BBK's ties to the team that helped to develop its patient and site engagement mobile app, My Clinical Study Buddy. BBK plans to tap into the unit's mHealth experience to boost its business. Release | More

Suggested Articles

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.

TriNetX's platform uses EHR data to help drug developers with clinical trial protocol design and study site and participant identification.

The company's Owkin Socrates platform applies transfer and federated learning to clinical research.